The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
A groundbreaking study reveals that the drug LL-341070 could help repair myelin damage, offering hope for vision restoration ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
News Medical on MSN1d
New drug candidate shows potential to restore vision in people with MSResearchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
The US Food and Drug Administration (FDA) is adding the risk of anaphylaxis to a new boxed warning of glatiramer acetate, a medicine for multiple sclerosis (MS). The agency issued the warning ...
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback